[
  {
    "id": 657,
    "name": "Bikanta",
    "slug": "bikanta",
    "former_names": [],
    "small_logo_thumb_url": "/company/thumb/missing.png",
    "website": "http://bikanta.com",
    "all_locations": "Berkeley, CA, USA",
    "long_description": "Bikanta is introducing revolutionary nanodiamond-based technology to push the boundaries of current medical imaging and diagnostics, allowing researchers to answer questions and medics to detect diseases that they currently cannot.\r\n\r\nA nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging.  Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques.   Bikantaâ€™s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.",
    "one_liner": "Nano-diamonds for cancer detection",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Diagnostics",
    "launched_at": 1398907618,
    "tags": [
      "Nanomedicine"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2014",
    "status": "Inactive",
    "industries": [
      "Healthcare",
      "Diagnostics"
    ],
    "regions": [
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/bikanta",
    "api": "https://yc-oss.github.io/api/batches/summer-2014/bikanta.json"
  },
  {
    "id": 1746,
    "name": "Sixfold Bioscience",
    "slug": "sixfold-bioscience",
    "former_names": [
      "Sixfold Bioscience "
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/b0f895aea5a3becf96dd016714d9e8aa78189e1b.png",
    "website": "https://www.sixfold.bio",
    "all_locations": "London, England, United Kingdom",
    "long_description": "Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression. \r\n\r\n",
    "one_liner": "Delivering RNA therapies.",
    "team_size": 27,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Drug Discovery and Delivery",
    "launched_at": 1509562895,
    "tags": [
      "Gene Therapy",
      "Nanomedicine",
      "Drug Delivery"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2018",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Drug Discovery and Delivery"
    ],
    "regions": [
      "United Kingdom",
      "Europe"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/sixfold-bioscience",
    "api": "https://yc-oss.github.io/api/batches/winter-2018/sixfold-bioscience.json"
  },
  {
    "id": 2028,
    "name": "Rejuvenation Technologies Inc.",
    "slug": "rejuvenation-technologies-inc",
    "former_names": [
      "Rejuvenation Technologies Inc.",
      "Rejuvenation Technologies"
    ],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/8570f907143e200c57848585eb12a16271d3643f.png",
    "website": "https://www.rejuvenationtech.com/",
    "all_locations": "Mountain View, CA, USA",
    "long_description": "Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging.  We are advancing TERT mRNA-based therapies to the clinic.",
    "one_liner": "We extend telomeres to extend the human health span",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1527534662,
    "tags": [
      "Anti-Aging",
      "Gene Therapy",
      "Nanomedicine"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2018",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United States of America",
      "America / Canada",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/rejuvenation-technologies-inc",
    "api": "https://yc-oss.github.io/api/batches/summer-2018/rejuvenation-technologies-inc.json"
  },
  {
    "id": 23522,
    "name": "Nuntius Therapeutics",
    "slug": "nuntius-therapeutics",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/490dca692522bd958768d197eafc08f9ea77c8fb.png",
    "website": "http://www.nuntiustx.com",
    "all_locations": "London, England, United Kingdom",
    "long_description": "",
    "one_liner": "Cell-specific genetic medicines",
    "team_size": 2,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Therapeutics",
    "launched_at": 1614621461,
    "tags": [
      "Gene Therapy",
      "Nanomedicine"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Winter 2021",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Therapeutics"
    ],
    "regions": [
      "United Kingdom",
      "Europe",
      "Remote",
      "Partly Remote"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/nuntius-therapeutics",
    "api": "https://yc-oss.github.io/api/batches/winter-2021/nuntius-therapeutics.json"
  },
  {
    "id": 29051,
    "name": "Nanograb",
    "slug": "nanograb",
    "former_names": [],
    "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/9ae1f1866a70286591b56aa5fd2f81bdf18af255.png",
    "website": "https://nanograb.com",
    "all_locations": "San Francisco, CA, USA",
    "long_description": "Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.",
    "one_liner": "AI-generated binders for targeted drug delivery",
    "team_size": 5,
    "industry": "Healthcare",
    "subindustry": "Healthcare -> Drug Discovery and Delivery",
    "launched_at": 1688618716,
    "tags": [
      "AI-powered Drug Discovery",
      "Nanomedicine",
      "Biotech",
      "Drug Delivery",
      "Therapeutics"
    ],
    "tags_highlighted": [],
    "top_company": false,
    "isHiring": false,
    "nonprofit": false,
    "batch": "Summer 2023",
    "status": "Active",
    "industries": [
      "Healthcare",
      "Drug Discovery and Delivery"
    ],
    "regions": [
      "United States of America",
      "America / Canada"
    ],
    "stage": "Early",
    "app_video_public": false,
    "demo_day_video_public": false,
    "app_answers": null,
    "question_answers": false,
    "url": "https://www.ycombinator.com/companies/nanograb",
    "api": "https://yc-oss.github.io/api/batches/summer-2023/nanograb.json"
  }
]
